Categories: Business

ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or “the Company”) (NASDAQ: ABL) for violations of the securities laws.

- Advertisement -


- Advertisement -

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Abacus is the subject of a report issued by Morpheus Research on June 4, 2025, titled: “Abacus Global Management: This $794 Million SPAC Is Yet Another Life Settlements Accounting Scheme Manufacturing Fake Revenue by Systematically Underestimating When People Will Die.” According to the report, the Company changed its portfolio valuation methodology to make it appear more profitable than it actually is. The report also alleges that the Company uses unusual methodologies to calculate life expectancy estimates and its co-founders have “red flags” in their past.

If you are a shareholder who suffered a loss, click here to participate.

- Advertisement -

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.

- Advertisement -

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

- Advertisement -

Contacts

- Advertisement -

The Schall Law Firm

Brian Schall, Esq.

310-301-3335

info@schallfirm.com
www.schallfirm.com

Business Wire

Recent Posts

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

September 06, 2025 14:30 ET  | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism…

6 hours ago

Lung Cancer Genetics Study Launches Open-Source Data Platform to Research Community

SAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, Troper Wojcicki Philanthropies (TWP),…

6 hours ago

Midea XPRESS MASTER Kitchen Revolutionizes Cooking Routines at IFA 2025

BERLIN, Sept. 6, 2025 /PRNewswire/ -- Midea Group, a 2025 Fortune Global 500 company, has unveiled…

6 hours ago

Midea SPACE MASTER Home Appliances Redefine Space Efficiency at IFA 2025

BERLIN, Sept. 6, 2025 /PRNewswire/ -- Midea Group, a 2025 Fortune Global 500 company, has…

6 hours ago

Olympian Artists programme launched for Milano Cortina 2026

The fifth edition of the programme features Simone Barlaam (Italy), Slaven Dizdarevic (Slovakia), Alexandra Ianculescu…

7 hours ago

IOC Executive Board meeting 18 and 19 September 2025 Information for the media

05 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) will hold a meeting on Thursday…

7 hours ago